The global Infectious Respiratory Disease Diagnostics market size in 2023 is 40626.6 million US dollars, and it is expected to be 34421.3 million US dollars by 2030, with a compound annual growth rate of -2.3% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Infectious Respiratory Disease Diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., and Siemens Healthineers AG. The share of the top 3 players in the Infectious Respiratory Disease Diagnostics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Infectious Respiratory Disease Diagnostics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Saliva accounted for XX% of Infectious Respiratory Disease Diagnostics market in 2023. Nasopharyngeal Swabs (NPS) share of XX%.
Immunoassay accounted for XX% of the Infectious Respiratory Disease Diagnostics market in 2023. Molecular Diagnostics accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Infectious Respiratory Disease Diagnostics Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Infectious Respiratory Disease Diagnostics market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Infectious Respiratory Disease Diagnostics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 4-6: Segmented the global Infectious Respiratory Disease Diagnostics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-10: Provide Americas, Europe, Asia-Pacific and Middle East & Africa Infectious Respiratory Disease Diagnostics market country segmentation data.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 12-14: Provide detailed Infectious Respiratory Disease Diagnostics market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey
Player list
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
Cepheid (Danaher Corporation)
Hologic, Inc.
Luminex Corporation
Quidel Corporation
Meridian Bioscience, Inc.
BioMérieux SA
Hain Lifescience GmbH
GenMark Diagnostics, Inc.
Types list
Saliva
Nasopharyngeal Swabs (NPS)
Anterior Nasal Region
Blood
Others
Application list
Immunoassay
Molecular Diagnostics
Microbiology
Other
Table of Content
1 Study Coverage
1.1 Infectious Respiratory Disease Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Infectious Respiratory Disease Diagnostics Market by Region
1.4.1 Global Infectious Respiratory Disease Diagnostics Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Infectious Respiratory Disease Diagnostics Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Infectious Respiratory Disease Diagnostics Revenue by Players
2.1.1 Global Infectious Respiratory Disease Diagnostics Revenue by Players (2019-2024)
2.1.2 Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Infectious Respiratory Disease Diagnostics Revenue in 2024
2.2 Global Infectious Respiratory Disease Diagnostics Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Infectious Respiratory Disease Diagnostics Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 F. Hoffmann-La Roche Ltd.
3.1.1 F. Hoffmann-La Roche Ltd. Information
3.1.2 F. Hoffmann-La Roche Ltd. Overview
3.1.3 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.1.4 F. Hoffmann-La Roche Ltd. Related Developments
3.2 Abbott Laboratories
3.2.1 Abbott Laboratories Information
3.2.2 Abbott Laboratories Overview
3.2.3 Abbott Laboratories Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.2.4 Abbott Laboratories Related Developments
3.3 Becton, Dickinson and Company
3.3.1 Becton, Dickinson and Company Information
3.3.2 Becton, Dickinson and Company Overview
3.3.3 Becton, Dickinson and Company Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.3.4 Becton, Dickinson and Company Related Developments
3.4 Thermo Fisher Scientific Inc.
3.4.1 Thermo Fisher Scientific Inc. Information
3.4.2 Thermo Fisher Scientific Inc. Overview
3.4.3 Thermo Fisher Scientific Inc. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.4.4 Thermo Fisher Scientific Inc. Related Developments
3.5 Siemens Healthineers AG
3.5.1 Siemens Healthineers AG Information
3.5.2 Siemens Healthineers AG Overview
3.5.3 Siemens Healthineers AG Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.5.4 Siemens Healthineers AG Related Developments
3.6 QIAGEN N.V.
3.6.1 QIAGEN N.V. Information
3.6.2 QIAGEN N.V. Overview
3.6.3 QIAGEN N.V. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.6.4 QIAGEN N.V. Related Developments
3.7 Bio-Rad Laboratories, Inc.
3.7.1 Bio-Rad Laboratories, Inc. Information
3.7.2 Bio-Rad Laboratories, Inc. Overview
3.7.3 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.7.4 Bio-Rad Laboratories, Inc. Related Developments
3.8 Cepheid (Danaher Corporation)
3.8.1 Cepheid (Danaher Corporation) Information
3.8.2 Cepheid (Danaher Corporation) Overview
3.8.3 Cepheid (Danaher Corporation) Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.8.4 Cepheid (Danaher Corporation) Related Developments
3.9 Hologic, Inc.
3.9.1 Hologic, Inc. Information
3.9.2 Hologic, Inc. Overview
3.9.3 Hologic, Inc. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.9.4 Hologic, Inc. Related Developments
3.10 Luminex Corporation
3.10.1 Luminex Corporation Information
3.10.2 Luminex Corporation Overview
3.10.3 Luminex Corporation Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.10.4 Luminex Corporation Related Developments
3.11 Quidel Corporation
3.11.1 Quidel Corporation Information
3.11.2 Quidel Corporation Overview
3.11.3 Quidel Corporation Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.11.4 Quidel Corporation Related Developments
3.12 Meridian Bioscience, Inc.
3.12.1 Meridian Bioscience, Inc. Information
3.12.2 Meridian Bioscience, Inc. Overview
3.12.3 Meridian Bioscience, Inc. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.12.4 Meridian Bioscience, Inc. Related Developments
3.13 BioMérieux SA
3.13.1 BioMérieux SA Information
3.13.2 BioMérieux SA Overview
3.13.3 BioMérieux SA Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.13.4 BioMérieux SA Related Developments
3.14 Hain Lifescience GmbH
3.14.1 Hain Lifescience GmbH Information
3.14.2 Hain Lifescience GmbH Overview
3.14.3 Hain Lifescience GmbH Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.14.4 Hain Lifescience GmbH Related Developments
3.15 GenMark Diagnostics, Inc.
3.15.1 GenMark Diagnostics, Inc. Information
3.15.2 GenMark Diagnostics, Inc. Overview
3.15.3 GenMark Diagnostics, Inc. Infectious Respiratory Disease Diagnostics Revenue and Gross Margin (2019-2024)
3.15.4 GenMark Diagnostics, Inc. Related Developments
4 Market Size by Type
4.1 Global Infectious Respiratory Disease Diagnostics Revenue by Type
4.2 Global Infectious Respiratory Disease Diagnostics Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global Infectious Respiratory Disease Diagnostics Revenue by Application
5.2 Global Infectious Respiratory Disease Diagnostics Market Size Growth by Application 2019-2024
6 Global Infectious Respiratory Disease Diagnostics Market Insights
6.1 Global Infectious Respiratory Disease Diagnostics Market Revenue 2019-2024
6.2 Global Infectious Respiratory Disease Diagnostics Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Infectious Respiratory Disease Diagnostics Market Size by Country
7.1.1 Americas Infectious Respiratory Disease Diagnostics Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Infectious Respiratory Disease Diagnostics Market Size by Country
8.1.1 Europe Infectious Respiratory Disease Diagnostics Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Infectious Respiratory Disease Diagnostics Market Size by Region
9.1.1 Asia Pacific Infectious Respiratory Disease Diagnostics Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Infectious Respiratory Disease Diagnostics Market Size by Country
10.1.1 Middle East and Africa Infectious Respiratory Disease Diagnostics Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Infectious Respiratory Disease Diagnostics Industry Trends
11.2 Infectious Respiratory Disease Diagnostics Market Drivers
11.3 Infectious Respiratory Disease Diagnostics Market Challenges
11.4 Infectious Respiratory Disease Diagnostics Market Restraints
12 Infectious Respiratory Disease Diagnostics Forecasted Market Size by Type
12.1 Global Infectious Respiratory Disease Diagnostics Forecasted Revenue by Type
12.2 Global Infectious Respiratory Disease Diagnostics Forecasted Market Size Growth by Type 2024-2030
13 Infectious Respiratory Disease Diagnostics Forecasted Market Size by Application
13.1 Global Infectious Respiratory Disease Diagnostics Forecasted Revenue by Application
13.2 Global Infectious Respiratory Disease Diagnostics Forecasted Market Size Growth by Application 2024-2030
14 Global Infectious Respiratory Disease Diagnostics Market Forecasts
14.1 Global Infectious Respiratory Disease Diagnostics Market Revenue Forecasts 2024-2030
14.2 Global Infectious Respiratory Disease Diagnostics Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer
List of Tables and Figures
Figure Infectious Respiratory Disease Diagnostics Picture
Table Product Definition of Infectious Respiratory Disease Diagnostics
Table Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Table Global Infectious Respiratory Disease Diagnostics Market by Region: 2019 VS 2024 VS 2030
Figure Global Infectious Respiratory Disease Diagnostics Revenue Market Size & Forecasts 2019-2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Infectious Respiratory Disease Diagnostics Revenue by Players (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Infectious Respiratory Disease Diagnostics in 2024
Figure Top 10 Largest Players of Infectious Respiratory Disease Diagnostics in 2024
Table Global Infectious Respiratory Disease Diagnostics Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Infectious Respiratory Disease Diagnostics Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table F. Hoffmann-La Roche Ltd. Overview
Table F. Hoffmann-La Roche Ltd. Revenue, Gross, Gross Margin 2019-2024
Table F. Hoffmann-La Roche Ltd. Related Developments
Table Company Profiles
Table Abbott Laboratories Overview
Table Abbott Laboratories Revenue, Gross, Gross Margin 2019-2024
Table Abbott Laboratories Related Developments
Table Company Profiles
Table Becton, Dickinson and Company Overview
Table Becton, Dickinson and Company Revenue, Gross, Gross Margin 2019-2024
Table Becton, Dickinson and Company Related Developments
Table Company Profiles
Table Thermo Fisher Scientific Inc. Overview
Table Thermo Fisher Scientific Inc. Revenue, Gross, Gross Margin 2019-2024
Table Thermo Fisher Scientific Inc. Related Developments
Table Company Profiles
Table Siemens Healthineers AG Overview
Table Siemens Healthineers AG Revenue, Gross, Gross Margin 2019-2024
Table Siemens Healthineers AG Related Developments
Table Company Profiles
Table QIAGEN N.V. Overview
Table QIAGEN N.V. Revenue, Gross, Gross Margin 2019-2024
Table QIAGEN N.V. Related Developments
Table Company Profiles
Table Bio-Rad Laboratories, Inc. Overview
Table Bio-Rad Laboratories, Inc. Revenue, Gross, Gross Margin 2019-2024
Table Bio-Rad Laboratories, Inc. Related Developments
Table Company Profiles
Table Cepheid (Danaher Corporation) Overview
Table Cepheid (Danaher Corporation) Revenue, Gross, Gross Margin 2019-2024
Table Cepheid (Danaher Corporation) Related Developments
Table Company Profiles
Table Hologic, Inc. Overview
Table Hologic, Inc. Revenue, Gross, Gross Margin 2019-2024
Table Hologic, Inc. Related Developments
Table Company Profiles
Table Luminex Corporation Overview
Table Luminex Corporation Revenue, Gross, Gross Margin 2019-2024
Table Luminex Corporation Related Developments
Table Company Profiles
Table Quidel Corporation Overview
Table Quidel Corporation Revenue, Gross, Gross Margin 2019-2024
Table Quidel Corporation Related Developments
Table Company Profiles
Table Meridian Bioscience, Inc. Overview
Table Meridian Bioscience, Inc. Revenue, Gross, Gross Margin 2019-2024
Table Meridian Bioscience, Inc. Related Developments
Table Company Profiles
Table BioMérieux SA Overview
Table BioMérieux SA Revenue, Gross, Gross Margin 2019-2024
Table BioMérieux SA Related Developments
Table Company Profiles
Table Hain Lifescience GmbH Overview
Table Hain Lifescience GmbH Revenue, Gross, Gross Margin 2019-2024
Table Hain Lifescience GmbH Related Developments
Table Company Profiles
Table GenMark Diagnostics, Inc. Overview
Table GenMark Diagnostics, Inc. Revenue, Gross, Gross Margin 2019-2024
Table GenMark Diagnostics, Inc. Related Developments
Table Global Infectious Respiratory Disease Diagnostics Revenue by Type (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Revenue Share by Type (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Revenue by Application (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Revenue Share by Application (2019-2024)
Figure Global Infectious Respiratory Disease Diagnostics Market Revenue 2019-2024
Table Global Infectious Respiratory Disease Diagnostics Revenue by Region (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Revenue Share by Region (2019-2024)
Figure Americas Infectious Respiratory Disease Diagnostics Revenue (2019-2024)
Figure Europe Infectious Respiratory Disease Diagnostics Revenue (2019-2024)
Figure Asia-Pacific Infectious Respiratory Disease Diagnostics Revenue (2019-2024)
Figure Middle East & Africa Infectious Respiratory Disease Diagnostics Revenue (2019-2024)
Table Americas Infectious Respiratory Disease Diagnostics Revenue by Country (2019-2024)
Table Americas Infectious Respiratory Disease Diagnostics Revenue Share by Country (2019-2024)
Figure United States Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Canada Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Mexico Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Brazil Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Argentina Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Table Europe Infectious Respiratory Disease Diagnostics Revenue by Country (2019-2024)
Table Europe Infectious Respiratory Disease Diagnostics Revenue Share by Country (2019-2024)
Figure Germany Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure France Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure U.K. Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Italy Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Russia Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Table Asia Pacific Infectious Respiratory Disease Diagnostics Revenue by Region (2019-2024)
Table Asia Pacific Infectious Respiratory Disease Diagnostics Revenue Share by Region (2019-2024)
Figure China Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Japan Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure South Korea Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure India Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Southeast Asia Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Australia Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Table Middle East and Africa Infectious Respiratory Disease Diagnostics Revenue by Country (2019-2024)
Table Middle East and Africa Infectious Respiratory Disease Diagnostics Revenue Share by Country (2019-2024)
Figure Turkey Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure Saudi Arabia Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Figure U.A.E Infectious Respiratory Disease Diagnostics Revenue Market Size (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Forecasted Revenue by Type (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Forecasted Revenue Share by Type (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Forecasted Revenue by Application (2019-2024)
Table Global Infectious Respiratory Disease Diagnostics Forecasted Revenue Share by Application (2019-2024)
Figure Global Infectious Respiratory Disease Diagnostics Market Revenue Forecasts 2024-2030
Table Global Infectious Respiratory Disease Diagnostics Forecasts Revenue by Region (2024-2030)
Table Global Infectious Respiratory Disease Diagnostics Forecasts Revenue Share by Region (2024-2030)
Figure Americas Infectious Respiratory Disease Diagnostics Forecasts Revenue and Growth (2024-2030)
Figure Europe Infectious Respiratory Disease Diagnostics Forecasts Revenue and Growth (2024-2030)
Figure Asia-Pacific Infectious Respiratory Disease Diagnostics Forecasts Revenue and Growth (2024-2030)
Figure Middle East & Africa Infectious Respiratory Disease Diagnostics Forecasts Revenue and Growth (2024-2030)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report